<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Media</title>
	<atom:link href="http://blog.curaxispharma.com/media/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.curaxispharma.com</link>
	<description></description>
	<lastBuildDate>Fri, 02 Jul 2010 07:35:32 -0400</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Sadly, the Failure of Pfizer/Medivation&#8217;s Phase III Trial on Dimebon is not a Surprise To Curaxis Pharma &#124;</title>
		<link>http://blog.curaxispharma.com/media/comment-page-1/#comment-70</link>
		<dc:creator>Sadly, the Failure of Pfizer/Medivation&#8217;s Phase III Trial on Dimebon is not a Surprise To Curaxis Pharma &#124;</dc:creator>
		<pubDate>Thu, 04 Mar 2010 03:47:00 +0000</pubDate>
		<guid isPermaLink="false">http://blog.curaxispharma.com/?page_id=179#comment-70</guid>
		<description>[...] Media [...]</description>
		<content:encoded><![CDATA[<p>[...] Media [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

